SEARCH

SEARCH BY CITATION

REFERENCES

  • 1
    Australia and New Zealand Dialysis and Transplant Registry (ANZDATA). 30th Annual report. 2006.
  • 2
    Go AS, Chertow GM, Fan D, McCulloch CE, Hsu C. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N. Engl. J. Med. 2004; 351: 1296305.
  • 3
    Anavekar NS, McMurray JJ, Velazquez EJ et al. Relation between renal dysfunction and cardiovascular outcomes after myocardial infarction. N. Engl. J. Med. 2004; 351: 128595.
  • 4
    ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction – executive summary. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to revise the 1999 guidelines for the management of patients with acute myocardial infarction). J. Am. Coll. Cardiol. 2004; 44: 671719.
  • 5
    Fraker TD Jr, Fihn SD; 2002 Chronic Stable Angina Writing Committee et al. 2007 chronic angina focused update of the ACC/AHA 2002 guidelines for the management of patients with chronic stable angina: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines Writing Group to devel. J. Am. Coll. Cardiol. 2007; 50: 226474.
  • 6
    US Renal Data System. USRDS 2004 Annual Data Report. Bethesda, MD: National Institute of Diabetes and Digestive and Kidney Diseases.
  • 7
    Kasiske BL, Cangro CB, Hariharan S et al. The evaluation of renal transplant candidates: clinical practice guidelines. Am. J. Transplant. 2001; 2: S595.
  • 8
    Gaston RS, Danovitch GM, Adams PL et al. The Report of a national conference on the wait list for renal transplantation. Am. J. Transplant. 2003; 3: 77585.
  • 9
    Gaston RS, Basadonna G, Cosio FG et al. Transplantation in the diabetic patient with advanced chronic kidney disease: a task force report. Am. J. Kidney Dis. 2004; 44: 52942.
  • 10
    Herzog CA, Ma JZ, Collins AJ. Long-term survival of renal transplant recipients in the United States after acute myocardial infarction. Am. J. Kidney Dis. 2000; 36: 14552.
  • 11
    Vasan RS, Sullivan LM, Wilson PW et al. Relative importance of borderline and elevated levels of coronary heart disease risk factors. Ann. Intern. Med. 2005; 142: 393402.
  • 12
    Meier-Kriesche HU, Port FK, Ojo AO et al. Effet of waiting time on renal transplant outcome. Kidney Int. 2000; 58: 131117.
  • 13
    Meier-Kriesche HU, Baliga R, Kaplan B. Decreased renal function is a strong risk factor for cardiovascular death after renal transplantation. Transplantation 2003; 75: 12915.
  • 14
    De Lima JJ, Sabbaga E, Vieira ML et al. Coronary angiography is the best predictor of events in renal transplant candidates compared with non-invasive testing. Hypertension 2003; 42: 26375.
  • 15
    Sharma R, Pellerin D, Gaze DC et al. Dobutamine stress echocardiography and the resting but not exercise electrocardiograph predict severe coronary artery disease in renal transplant candidates. Nephrol. Dial. Transplant. 2005; 20: 220714.
  • 16
    Rabbat CG, Treleaven DJ, Russell JD, Ludwin D, Cook DJ. Prognostic value of myocardial perfusion studies in patients with end-stage renal disease assessed for kidney or kidney-pancreas transplantation: a meta-analysis. J. Am. Soc. Nephrol. 2003; 14: 4319.
  • 17
    Patel RK, Mark PB, Johnston N et al. Prognostic value of cardiovascular screening in potential renal transplant recipients: a single-center prospective observational study. Am. J. Transplant. 2008; 167383.
  • 18
    Hueb W, Lopes NH, Gersh BJ et al. Five-year follow-up of the Medicine, Angioplasty, or Surgery Study (MASS II): a randomized controlled clinical trial of 3 therapeutic strategies for multivessel coronary artery disease. Circulation 2007; 115: 10829.
  • 19
    Shaw LJ, Berman DS, Maron DJ et al. Optimal medical therapy with or without percutaneous coronary intervention to reduce ischemic burden: results from the Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation (COURAGE) trial nuclear substudy. Circulation 2008; 117: 128391.
  • 20
    VA Coronary Artery Byass Co-operative Study Group. Eighteen year follow-up in the Veteran Affairs Co-operative Study of Coronary Artery Bypass Surgery for Stable Angina. Circulation 1992; 86: 12130.
  • 21
    Manske CL, Wang Y, Rector T, Wilson RF, White CW. Coronary revascularisation in insulin-dependent diabetic patients with chronic kidney failure. Lancet 1992; 340: 9981002.
  • 22
    Holzmann MR, Ahnve S, Hammar N et al. Creatinine clearance and risk of early mortality in patients undergoing coronary artery bypass grafting. J. Thorac. Cardiovasc. Surg. 2005; 130: 746.
  • 23
    Gruberg L, WEissman NJ, Pichard AD et al. Impact of renal function on morbidity and mortality after percutaneous aortocoronary saphenous vein graft intervention. Am. Heart J. 2003; 145: 52934.
  • 24
    Lok CE, Austin PC, Want H, Tu JV. Impact of renal insufficiency on short and long-term outcomes after cardiac surgery. Am. Heart J. 2004; 148: 43038.
  • 25
    Van De Wal RMA, Van Brussel BL, Voors AA et al. Mild preoperative renal dysfunction as a predictor of long-term clinical outcome after coronary bypass surgery. J. Thorac. Cardiovasc. Surg. 2005; 129: 33035.
  • 26
    Cooper WA, O'Brien SM, Thourani VH et al. Impact of renal dysfunction on outcomes of coronary artery bypass surgery: results from the society of thoracic surgeons national adult cardiac database. Circulation 2006; 113: 106370.
  • 27
    Akman B, Bilgic A, Sasak G, Sezer A. Mortality risk factors in chronic renal failure patients after coronary artery bypass grafting. Ren. Fail. 2007; 29: 8238.
  • 28
    Chonchol MB, Aboyans V, Lacroiz P, Smits G, Berl T, Laskar M. Long-term outcomes after coronary artery bypass grafting: pre-operataive kidney function is prognostic. J. Thorac. Cardiovasc. Surg. 2007; 134: 6839.
  • 29
    Hillis GS, Croal BL, Buchan KG et al. Renal function and outcome from coronary artery bypass grafting: Impact on mortality after a 2.3-year followup. Circulation 2006; 113: 105662.
  • 30
    Zakeri R, Freemantle N, Barnett V et al. Relation between mild renal impairment and outcomes after coronary artery bypass grafting. Circulation 2005; 112: 27075.
  • 31
    Naidu SS, Selzer F, Jacobs A et al. Renal Insufficiency is an independent predictor of mortality after percutaneous coronary artery intervention. Am. J. Cardiol. 2003; 92: 116064.
  • 32
    Best PJ, Lennon R, Ting HH et al. The impact of renal insufficiency on clinical outcomes in patients undergoing percutaneous coronary interventions. JACC 2002; 39: 111319.
  • 33
    Sedeghi HM, Stone GW, Grines CL et al. Impact of renal insufficiency in patients undergoing primary angioplasty for acute myocardial infarction. Circulation 2003; 108: 276975.
  • 34
    Ting HH, Tahirkheli NK, Berger PB et al. Evaluation of long-term survival after successful percutaneous coronary artery intervention among patients with chronic renal failure. Am. J. Cardiol. 2001; 87: 63033.
  • 35
    Reinecke H, Trey T, Matzkies F, Fobker M, Breithardt G, Schaefer RM. Grade of chronic renal failure, and acute and long-term outcome after percutaneous coronary intervention. Kidney Int. 2003; 63: 696701.
  • 36
    Rubenstein MH, Harrell LC, Sheynberg BV, Schunkert H, Bazari H, Palacios IF. Are patients with renal failure good candidates for percutaneous coronary revascularization in the new device era? Circulation 2000; 102: 296672.
  • 37
    Le F. Angioplasty and stenting in patients with renal disease. Heart 2000; 83: 79.
  • 38
    Lemos PA, Arampatzis CA, Hoye A et al. Impact of baseline renal function on mortality after percutaneous coronary intervention with sirolimus-eluting stents or bare metal stents. Am. J. Cardiol. 2005; 95: 16772.
  • 39
    Marzocchi A, Saia F, Piovaccari G et al. Long-term safety and efficacy of drug-eluting stents: two-year results of the REAL (REgistro AngiopLastiche dell'Emilia Romagna) Multicenter Registry. Circulation 2007; 115: 31818.
  • 40
    Halkin A, Mehran R, Casey CW. Impact of moderate renal insufficiency on restenosis and adverse clinical events after paclitaxel-eluting and bare metal stent implantation: results from the TAXUS-IV Trial. Am. Heart J. 2005; 150: 116370.
  • 41
    Szczech LA, Reddan DN, Owen WF et al. Differential survival after coronary revascularization procedures among patients with renal insufficiency. Kidney Int. 2001; 60: 2929.
  • 42
    Hemmelgarn BR, Southern D, Culleton BF, Mitchell B, Knudtson ML, Ghali WA. Survival after coronary revascularization among patients with kidney disease. Circulation 2004; 110: 189095.
  • 43
    Stigant C, Izadnegahdar M, Levin A, Buller CE, Humphries KH. Outcomes after percutaneous coronary interventions in patients with CKD: improved outcome in the stenting era. Am. J. Kidney Dis. 2005; 45: 10029.
  • 44
    Horst M, Mehlhorm U, Hoerstrup SP, Suedkamp M, De Vivie ER. Cardiac surgery in patients with end-stage renal failure. Ann. Thorac. Surg. 2000; 69: 96101.
  • 45
    Krabatsch T, Yeter R, Hetzer R. Coronary Surgery in patients requiring chronic dialysis. Kidney Blood Press. Res. 2005; 28: 27074.
  • 46
    Wong D, Thompson G, Buth K, Sullivan J, Ali I. Angiographic coronary diffuseness and outcomes in dialysis patients undergoing coronary artery bypass grafting surgery. Eur. J. Cardiothorac. Surg. 2003; 24: 38892.
  • 47
    Herzog CA, Ma JZ, Collins AJ. Long-term outcome of dialysis patients in the United Stages with coronary revascularization procedures. Kidney Int. 1999; 56: 32432.
  • 48
    Herzog CA, Ma JZ, Collins AJ. Comparative survival of dialysis patients in the United States after coronary angioplasty, coronary artery stenting and coronary artery bypass surgery and impact of diabetes. Circulation 2002; 106: 220711.
  • 49
    Schoebel F, Gradaus F, Ivens K et al. Restenosis after elective coronary artery balloon angioplasty in patients with end stage renal disease: a case-control study using quantitative coronary angiography. BMJ 2997: 33742.
  • 50
    Kahn JK, Rutherford BD, McConahay DR, Johnson WL, Giorgi LV, Hartzier GO. Short- and long-term outcome of percutaneous transluminal coronary angioplasty in chronic dialysis patients. Am. Heart J. 1990; 119: 4849.
  • 51
    Agirbasli M, Weintraub WS, Chang GL et al. Outcome of coronary revascularization in patients on renal dialysis. Am. J. Cardiol. 2000; 86: 3959.
  • 52
    Rinehart AL, Herzog CA, Collins AJ, Flack JM, Ma JZ, Opsahl JA. A comparison of coronary angioplasty and coronary artery bypass grafting outcomes in chronic dialysis patients. Am. J. Kidney Dis. 1995; 25: 28190.
  • 53
    Herzog CA, Ma JZ, Collins AJ. Long-term outcome of renal transplant recipients in the United States after coronary artery revascularization procedures. Circulation 2004; 109: 286671.
  • 54
    Fellstrom B, AGm Soveri J, Cole I et al. Renal dysfunction is a strong and independent risk factor for mortality and cardiovascular complications in renal transplantation. Am. J. Transplant. 2005; 5: 198691.
  • 55
    McFalls EO, Ward HB, Moritz TE et al. Coronary-Artery Revascularization before Elective Major Vascular Surgery. N. Engl. J. Med. 2004; 351: 2795804.
  • 56
    FRISC-2 Investigators. Invasive compared with non-invasive treatment in unstable coronary artery diseases. FRISC II prospective randomised multi-centre stud. Lancet 1999; 354: 70815.
  • 57
    Johnston N, Jernberg T, Lagerqvist B, Wallentin L. Early invasive treatment benefits patients with renal dysfunction in unstable coronary artery disease patients. Am. Heart J. 2006; 152: 10528.
  • 58
    Januzzi JL, Cannon CP, DiBattiste PM et al. Insufficiency on early invasive management in patients with acute coronary syndromes. Am. J. Cardiol. 2002; 90: 12469.